- Home
- / Biom'Up
Biom'Up
Total Funding
$74.6 M
Revenue
€1.2 M
FY, 2018
Biom'Up Summary
Company Summary
- Overview
- Biom'Up designs, develops, manufactures, and sells collagen-based absorbable medical devices. It offers products under the HEMOBLAST and HEMOSNOW brands for surgical specialties, such as orthopedic, spine, cardiothoracic, general, maxillofacial, and dental surgeries.
- Type
- Private
- Status
- Active
- Founded
- 2005
- HQ
- Saint-Priest, FR | view all locations
- Website
- http://www.biomup.com
- Cybersecurity rating
Table of Contents
Key People
Patrice Ferrand, Chief Executive Officer, Chairman
Gene Mack, CFO
William D. Spotnitz, Chief Medical Officer
LocationsView all
2 locations detected
Saint-Priest, Auvergne-Rhône-Alpes HQ
France
8 Allée Irène Joliot-Curie
Macquarie Park, NSW
Australia
Level 8/15 Talavera Rd
Biom'Up Financials
Summary Financials
- Revenue (FY, 2018)
- €1.2M
- Gross profit (FY, 2018)
- (€1.4M)
- Net income (FY, 2018)
- (€40.6M)
- Cash (FY, 2018)
- €30.6M
- EBIT (FY, 2018)
- (€38.3M)